BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18922925)

  • 1. Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.
    Hitoshi Y; Harris BT; Liu H; Popko B; Israel MA
    Cancer Res; 2008 Oct; 68(20):8507-15. PubMed ID: 18922925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
    Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
    Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
    Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
    Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified GFAP promoter auto-regulates tet-activator expression for increased transactivation and reduced tTA-associated toxicity.
    Barton MD; Dunlop JW; Psaltis G; Kulik J; DeGennaro L; Kwak SP
    Brain Res Mol Brain Res; 2002 May; 101(1-2):71-81. PubMed ID: 12007834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
    Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
    Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human glial fibrillary acidic protein: complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes.
    Bongcam-Rudloff E; Nistér M; Betsholtz C; Wang JL; Stenman G; Huebner K; Croce CM; Westermark B
    Cancer Res; 1991 Mar; 51(5):1553-60. PubMed ID: 1847665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.
    Ellis JA; Castelli M; Bruce JN; Canoll P; Ogden AT
    Neurosurgery; 2012 Jan; 70(1):198-204; discussion 204. PubMed ID: 21760556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
    Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC
    Cancer Res; 2004 Jul; 64(14):4783-9. PubMed ID: 15256447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model.
    Torisu R; Suzuki SO; Masui K; Yoshimoto K; Mizoguchi M; Hashizume M; Canoll P; Goldman JE; Sasaki T; Iwaki T
    Brain Tumor Pathol; 2011 Feb; 28(1):33-42. PubMed ID: 21210235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
    Holland EC; Hively WP; DePinho RA; Varmus HE
    Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
    Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
    Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFRα expression distinguishes GFAP-expressing neural stem cells from PDGF-responsive neural precursors in the adult periventricular area.
    Chojnacki A; Mak G; Weiss S
    J Neurosci; 2011 Jun; 31(26):9503-12. PubMed ID: 21715615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation.
    Jiang Y; Boije M; Westermark B; Uhrbom L
    Neoplasia; 2011 Jun; 13(6):492-503. PubMed ID: 21677873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas.
    Fukuyama K; Matsuzawa K; Hubbard SL; Dirks PB; Murakami M; Rutka JT
    Anticancer Res; 1996; 16(3A):1251-7. PubMed ID: 8702246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
    Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GFAP promoter drives Müller cell-specific expression in transgenic mice.
    Kuzmanovic M; Dudley VJ; Sarthy VP
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3606-13. PubMed ID: 12882814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.